Mov Disord Vol 34, Suppl 2 Archives - Page 152 of 217 - MDS Abstracts

2019 International Congress
Successful treatment of secondary dystonia with deep brain stimulation of the globus pallidus internus
S. Hendrickx, PH. Bourgeois, A. Tieleman, D. Vanhauwaert, T. Couvreur, O. van Damme (Roeselare, Belgium)
Objective: Improving targeting accuracy in the treatment of secondary dystonia with DBS of GPi Background: Dystonia is a very disabling disease. Deep brain stimulation (DBS) of…
2019 International Congress
Local anesthesia vs general anesthesia in STN-dDBS operation: a clinical comparison of the outcome of patients with advanced Parkinson’s disease
M. Koivu, J. Resendiz-Nieves, J. Eerola-Rautio, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)
Objective: To compare clinical outcome of patients with Parkinson’s disease (PD) treated with directional deep brain (dDBS) stimulation undergoing subthalamic deep brain stimulation operation (STN-DBS)…
2019 International Congress
Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus
S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril (Moscow, Russian Federation)
Objective: Assessment of the dynamics of the clinical manifestations of dofamine dysregulation syndrome (DDS) and the severity of dyskinesias in patients with Parkinson`s Disease (PD)…
2019 International Congress
Effect of global cognitive score on motor and quality of life outcomes after deep brain stimulation in patients with Parkinson’s disease or essential tremor
E. Staikova, D. Loring, M. Delong, S. Triche, C. Buetefisch, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, S. Miocinovic (Atlanta, GA, USA)
Objective: To determine if preoperative global cognitive score, Mattis Dementia Rating Scale 2nd Edition (DRS-2), predicts motor and quality of life (QoL) outcomes in patients…
2019 International Congress
BeatPark: a new wearable device for gait auto-rehabilitation in Parkinson’s disease delivering adapted musical stimulation.
V. Cochen Decock, D. Dotov, L. Damm, MC. Picot, P. Ihalainen, V. Driss, C. Geny, B. Bardy, S. Dalla Bella (Montpellier, France)
Objective: The aim of our study is to evaluate safety, tolerance and efficacy of a new device called BeatPark, delivering individualized musical stimulation for gait…
2019 International Congress
Can Google Glass improve freezing of gait in parkinsonism? A pilot study
A. Lee, N. Hellmers, M. Vo, P. Popa, C. Henchcliffe, H. Sarva, C. Campbell (New York, NY, USA)
Objective: To determine feasibility of Google Glass (GG) technology to improve freezing of gait (FOG) in parkinsonism Background: FOG is a motor block often resistant…
2019 International Congress
Neuroart: A Hummingbird in the Cage of the Brain
A. Kleinert (Tuxtla Gutierrez, Mexico)
Objective: The main objective of this work is to expose th paintings of an artist with myelomeningocele and her fascination with hummingbirds in patients with…
2019 International Congress
Deep brain stimulation in children: analysis of indication, outcome and complications
DR. Maiti (Cleveland, OH, USA)
Objective: Deep brain stimulation for pediatric movement disorder has been contemplated much less than adult counterpart. We discuss the outcome of DBS int them children…
2019 International Congress
Dietary Vitamin E as a protective factor for Parkinson’s Disease: a clinical and experimental study
T. Schirinzi, G. Martella, P. Imbriani, G. Di Lazzaro, M. Alwardat, M. Pierantozzi, N. Mercuri, A. Pisani (Rome, Italy)
Objective: To test if a higher dietary intake of Vitamin E might represent a protective factor in Parkinson’s disease (PD). Background: Effective disease-modifying treatments are…
2019 International Congress
Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease
E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)
Objective: To follow clinical/cognitive and cortical thickness (CT) changes in Parkinson’s disease (PD) patients with stable apathy (PD-sAp), without apathy (PD-noAp), and patients who developed…